Article
GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer
24 Aug 2025
Abstract excerpt
Alterations in neurotransmitter signaling can influence colorectal cancer (CRC). In a large, randomized Phase III clinical trial (CALGB/SWOG 80405) involving patients with metastatic CRC, high expression of gamma-aminobutyric acid (GABA) pathway gene GAD1 and low expression of ABAT, indicative of a GABAergic environment, were associated with worse progression-free survival and overall survival outcomes. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
